WEDNESDAY, Dec. 10, 2025 — A new study suggests popular GLP-1 drugs, like Ozempic and Zepbound, may not lower cancer risk as some had hoped.Researchers analyzed 48 randomized trials including 94,245 adults who were overweight, obese or had type 2 d…
Blog
Leave a Reply